$VEEV Posts 16% Revenue Growth, EPS Up 23% in Latest Quarter
Veeva Systems reported 16% revenue growth and 23.2% EPS growth in its latest quarter. Here's what the numbers say about $VEEV heading into the back half of 2026.
$VEEV reported earnings on June 3, 2026, delivering year-over-year revenue growth of 16.0% and earnings-per-share growth of 23.2%. The earnings growth outpacing revenue growth is a meaningful signal — it suggests Veeva is expanding margins, not just the top line.
At a current price of $180.42 and a market cap of $29.44B, the stock carries a trailing P/E of 33.7. The forward P/E drops to 18.5, which implies the market is pricing in a significant step-up in earnings over the next twelve months. That gap between trailing and forward multiples is wide enough to notice.
The ACCE score sits at 57 out of 100, landing in neutral territory. The analyst consensus target is $262.68, which represents a substantial gap above the current price. We don't have guidance commentary from management to anchor expectations for the next quarter or full year, so that target should be read in that context.
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.
Veeva pays no dividend, consistent with its profile as a growth-oriented software company reinvesting into the business.
What it means
The 23.2% EPS growth number is the headline here. For a healthcare software company operating in a specialized vertical — life sciences CRM, clinical data, regulatory content — that kind of earnings acceleration on 16% revenue growth points to operating leverage taking hold. Costs are not growing as fast as revenue.
The forward P/E of 18.5 is notably lower than the trailing figure of 33.7. That compression only makes sense if analysts expect earnings to grow sharply in the coming year. If those estimates prove accurate, the current price looks different than the trailing multiple alone suggests. If they don't, the stock has less cushion.
The ACCE score of 57 reflects a balanced picture — not a strong buy signal, not a red flag. It sits in the range where the fundamentals are solid but the risk-reward isn't one-sided.
We don't have management's forward guidance from this earnings call, which limits how much weight to put on near-term projections. For the current price and full analyst data, visit acceinvestments.com/stocks/VEEV.
ACCE scores thousands of stocks across valuation models matched to each company, with fair value, conviction and the full thesis on every name. Start free, no card required.
